The Effectiveness of Bulevirtide Monotherapy is Similar in Chronic Hepatitis Delta Patients with & without Cirrhosis: Results from the Prospective Multicenter D-SHIELD Study

Conference Reports for NATAP

The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025


The Effectiveness of Bulevirtide Monotherapy is Similar in Chronic Hepatitis Delta Patients with & without Cirrhosis: Results from the Prospective Multicenter D-SHIELD Study

	AASLD 2025 Nov 7-11 Wash DC